eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | diffuse large b-cell lymphoma |
| Comorbidity | C0019163|hepatitis b |
| Sentences | 4 |
| PubMedID- 22029053 | "prospective analysis of hepatitis b virus reactivation in patients with diffuse large b-cell lymphoma after rituximab combination chemotherapy". |
| PubMedID- 25848698 | We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection. |
| PubMedID- 26058465 | Conclusions: dlbcl patients with resolved hepatitis b may have a higher risk of developing hbv reactivation and hepatitis than hbsag-negative/hbcab-negative patients. |
| PubMedID- 20837949 | Prospective analysis of hepatitis b virus reactivation in patients with diffuse large b-cell lymphoma after rituximab combination chemotherapy. |
Page: 1